Stocks & Investing
Fri, July 21, 2023
[ Fri, Jul 21st 2023
] - WOPRAI
Fri, January 31, 2020
[ Fri, Jan 31st 2020
] - WOPRAI
Wed, November 20, 2019
[ Wed, Nov 20th 2019
] - WOPRAI
Thu, October 17, 2019
[ Thu, Oct 17th 2019
] - WOPRAI
Thu, February 22, 2018
[ Thu, Feb 22nd 2018
] - WOPRAI
Thu, February 1, 2018
[ Thu, Feb 01st 2018
] - WOPRAI
Fri, January 5, 2018
Wed, October 18, 2017
[ Wed, Oct 18th 2017
] - WOPRAI
Fri, September 22, 2017
[ Fri, Sep 22nd 2017
] - WOPRAI
Mon, July 24, 2017
[ Mon, Jul 24th 2017
] - WOPRAI
Wed, February 1, 2017
Mon, July 6, 2015
[ Mon, Jul 06th 2015
] - WOPRAI
Tue, July 31, 2012
[ Tue, Jul 31st 2012
] - WOPRAI
Wed, March 14, 2012
[ Wed, Mar 14th 2012
] - WOPRAI
Ying Huang Maintained (VRTX) at Strong Buy with Increased Target to $400 on, Jul 21st, 2023
Ying Huang of B of A Securities, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $350 to $400 on, Jul 21st, 2023.
Ying has made no other calls on VRTX in the last 4 months.
There are 20 other peers that have a rating on VRTX. Out of the 20 peers that are also analyzing VRTX, 4 agree with Ying's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Reiterated at Hold with Increased Target to $340 on, Friday, June 30th, 2023
- Brian Abrahams of "RBC Capital" Reiterated at Hold and Held Target at $323 on, Thursday, June 22nd, 2023
- Brian Skorney of "Baird" Maintained at Hold with Increased Target to $325 on, Tuesday, May 2nd, 2023
- Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $340 on, Tuesday, May 2nd, 2023
These are the ratings of the 16 analyists that currently disagree with Ying
- Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $360 on, Wednesday, June 28th, 2023
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $379 on, Monday, June 26th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $380 on, Monday, June 26th, 2023
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $365 on, Friday, June 23rd, 2023
- Myles Minter of "William Blair" Initiated at Buy on, Tuesday, May 30th, 2023
- Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $385 on, Thursday, May 4th, 2023
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $400 on, Wednesday, May 3rd, 2023
- William Pickering of "Bernstein" Maintained at Buy with Increased Target to $363 on, Wednesday, May 3rd, 2023
- Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $399 on, Tuesday, May 2nd, 2023
- Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $385 on, Tuesday, May 2nd, 2023
- Evan Seigerman of "BMO Capital" Maintained at Buy and Held Target at $385 on, Tuesday, May 2nd, 2023
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $384 on, Tuesday, May 2nd, 2023
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $410 on, Tuesday, May 2nd, 2023
- Jessica Fye of "JP Morgan" Maintained at Buy and Held Target at $345 on, Tuesday, May 2nd, 2023
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $456 on, Tuesday, May 2nd, 2023
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Wednesday, March 29th, 2023
